Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Inflazyme contracts Inveresk Research for IND support

Sep. 9, 1997

Celltech prepares improved PDE IV inhibitors

Sep. 8, 1997

Licensing agreement signed for OxSODrol

Sep. 5, 1997

Merck's asthma treatment receives first approvals

Sep. 4, 1997

Celltech prepares PDE IV inhibitors

Sep. 4, 1997

Sepracor's levalbuterol NDA accepted by FDA

Sep. 4, 1997

LT antagonist/antihistamine combination highly effective against EAR/LAR

Sep. 3, 1997

ET antagonists for asthma

Sep. 2, 1997

Anti-IgE antibody inhibits allergen-induced EAR

Sep. 2, 1997

North American clinical trials with LiquiVent to be reinitiated

Sep. 1, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...